Morphic Medical, Inc. engages in the design, development, manufacture, and marketing of medical devices for non-surgical approaches to treat type 2 diabetes and obesity. The company offers EndoBarrier, a medical implant for the treatment of patients with type 2 diabetes and reduction of obesity. It serves health care providers and third-party distributors. The company sells its products primarily in Europe, the Middle East, the Asia Pacific, Australia, and South America. Morphic Medical, Inc. was formerly known as GI Dynamics, Inc. Morphic Medical, Inc. was incorporated in 2003 and is headquartered in Boston, Massachusetts.